SCAM ALERT

New scam letters and calls target medical practitioners.

Click here to learn more.

Safe Online Pharmacies

Learn how to check to see if your medication came from a legitimate online pharmacy.

Click here to learn more.

Electronic Prescription Fraud

DEA Warns Pharmacies of Electronic Prescription Fraud.

Click here to learn more.

TELEMEDICINE FLEXIBILITIES

DEA extends telemedicine flexibilities through 2025.

Click here to read more.

DATA-Waiver

Waiver registration is no longer required to treat patients with opioid use disorder.

Obtain or Renew DEA Registration

Save Time, Apply Online

CLICK HERE TO GET STARTED!

DEA FORMS & APPLICATIONS

NEED TO REGISTER, REPORT OR SUBMIT A TIP?

OUR FORMS & APPLICATIONS WILL ASSIST YOU

CLICK HERE TO GET STARTED!

Year Round Pharmaceutical Disposal

SEARCH FOR YEAR ROUND PHARMACEUTICAL DISPOSAL LOCATIONS

CLICK HERE TO GET STARTED!

INFORMATIONAL DOCUMENTS

PUBLICATIONS & MANUALS

CLICK HERE TO GET STARTED!

Follow @DEA on Twitter

LOOK FOR #DEADIVERSION

CLICK HERE TO GET STARTED!

CONTROLLED SUBSTANCE SCHEDULES

REVIEW THE LIST OF CONTROLLED SUBSTANCES, EXEMPTED LISTS & DEFINITION OF CONTROLLED SUBSTANCE SCHEDULES

CLICK HERE TO GET STARTED!

Registration

Forms &Applications

Hours 8:30am–5:50pm ET

Phone 1-800-882-9539

Email Email Us

DEA Offices Find Local Office

Contact Us

Resources

If you are applying as a medical marijuana dispensary, you must apply at https://apps.deadiversion.usdoj.gov/webforms2/spring/newLogin

The Diversion Control Division has released the beta version of a new AI chatbot to assist the public and registrants with Diversion Control Division policy and processes. Click here!

Welcome

Go to Registration

Forms & Applications

Go to Forms

Questions & Answers

Go to Q&A

Meetings & Events

Go to Meetings

Guidance Documents Portal

Go to Portal

Go to Disposal

Controlled Substance Schedules

Go to Schedules

Publications & Manuals

Go to Pubs

Report Suspicious Chemical Orders

Go to Chemical
Reporting

MATE/8-hour Training Requirements

Go to MATE/8-hour
Training Requirements

In The News

(April, 2026)

Fentanyl Free America Summit/CADCA Partnership

(April, 2026)

Fentanyl Pre-Cursor Chemical Awareness

Pharmacy Enforcement Cases

(January 22, 2026)

El Paso Doctor Enters $200,000 Settlement Following State and Federal Fraud Allegations

(January 20, 2026)

Portland Veterinarian Sentenced for Diverting Controlled Substances for Personal Use

(December 3, 2025)

Southern New Mexico Medical Spa Operator Settles Allegations of Controlled-Substance Recordkeeping Violations

(November 19, 2025)

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

(September 30, 2024)

U.S. Attorney Announces Charges Against 18 Defendants In Scheme to Manufacture and Distribute Millions of Deadly Counterfeit Pharmaceuticals Through Fake Online Pharmacies

(September 11, 2025)

Clay County Pharmacy Investigation and Prosecution Ends in Guilty Pleas

(August 7, 2025)

Putnam County Veterinarian Ordered to Pay $956,709 in Civil Penalties

(July 14, 2025)

Attorney General Mayes Announces Conviction of Tucson Psychiatrist for Sexual Assault, Sexual Abuse, and Fraud

(July 9, 2025)

Gastonia Pharmacist Sentenced to Prison for Illegal Distribution of Oxycodone

(July 1, 2025)

UW Medicine Resident Physician at Seattle Children’s Hospital Charged for Diverting Fentanyl

(June 30, 2025)

2025 National Health Care Fraud Takedown

(May 6, 2025)

Franklin, Kentucky Pharmacist and Spouse Sentenced to Federal Prison

(March 24, 2024)

Three Convicted for Fraudulently Billing Over $8 Million to Medicare and Medicaid Through Opioid Addiction Treatment Clinics in Kentucky

(March 19, 2025)

California Couple Sentenced to Prison for Mail Order Drug Trafficking

(March 14, 2025)

Doctor Sentenced for Health Care Fraud and Money Laundering

(February 12, 2025)

Florence Doctor Sentenced for Distributing Oxycodone in "Sex for Scripts" Scheme

What's New

(September 09, 2026)

Diversion Chatbot—Beta Release

(September 23, 2026)

Proposed Rule: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I (PDF)

(September 28, 2026)

Cargill, Incorporated (PDF)

(September 28, 2026)

Irvine Labs, Inc. (PDF)

(September 28, 2026)

Benuvia Operations, LLC (PDF)

(September 24, 2026)

Eli-Elsohly Laboratories (PDF)

(September 24, 2026)

Cambridge Isotope Laboratories, Inc. (PDF)